SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000819050-20-000164
Filing Date
2020-07-15
Accepted
2020-07-15 16:57:20
Documents
5
Period of Report
2020-07-15

Document Format Files

Seq Description Document Type Size
1 PRE 14A a20200716pre-14a.htm PRE 14A 665235
2 image11.jpg GRAPHIC 295292
3 image211.jpg GRAPHIC 136271
4 image311.jpg GRAPHIC 31312
5 image411.jpg GRAPHIC 203830
  Complete submission text file 0000819050-20-000164.txt   1584317
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-21088 | Film No.: 201029984
SIC: 2836 Biological Products, (No Diagnostic Substances)